NexgenRx (TSE:NXG) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NexgenRx, a Canadian full-service Third-Party Administrator and Technology Solutions Provider, has announced the issuance of 195,312 common shares at $0.32 each, completing the fourth equity payment under its Consulting Agreement with PBM Management Services. The shares, which are part of the company’s compensation for consulting services, will be held for a statutory four-month period expiring November 19, 2024.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.